Biosciences Area

  • About Biosciences
    • Leadership
    • Area Operations Centers
    • Strategic Plan and Reports
    • Strategic Programs Development Group
    • Contact Information
  • Our Science
    • Area Programs
    • Strategic Initiatives
    • Biological Systems and Engineering
    • Environmental Genomics and Systems Biology
    • Molecular Biophysics and Integrated Bioimaging
    • DOE Joint Genome Institute
  • Media and Events
    • News
    • Announcements
    • Behind the Breakthroughs
    • Events Calendar
    • Seminar Series
  • Staff Resources
    • Commonly Used Acronyms
    • Communications
    • Hiring and Recruitment
    • Hybrid & Telework Resources
    • IDEA
    • Intellectual Property, Industry Engagement, and Entrepreneurship
    • LDRD Information
    • Logos and Templates
    • Mentoring Program
  • Search

Structures Signal Fresh Targets for Anticancer Drugs

October 4, 2022

Great progress has recently been made in understanding the cascade of molecular signals that trigger cell replication, and compounds that block these signals when they run amok are of great interest as potential cancer treatments. While such drugs have shown efficacy in the clinic, resistance mechanisms that reactivate the signaling pathway have emerged. Thus, it is vitally important to gain a molecular-level understanding of the various ways in which signaling proteins interact with each other.

SHOC2-PP1C-RAS complex
A complex of three proteins—SHOC2, PP1C, and RAS—plays a key role in signaling cells to replicate and is thus a potential target for anticancer drug development. Left: Cryo-electron microscopy (cryoEM) density map of the complex. Right: Ribbon structure showing the active site and a bound molecule (yellow) necessary for complex formation.

To that end, a research group from Genentech used a suite of biochemical and structural methods to learn how an assembly of three proteins works together to transmit signals for cell division. The latter included small-angle x-ray scattering (SAXS) on the SIBYLS beamline (12.3.1) at the Advanced Light Source (ALS). SAXS captures snapshots of large, flexible protein complexes suspended in solution, enabling the researchers to visualize dynamic aspects of complex formation. At the beamline, samples were also analyzed using size exclusion chromatography (SEC) and multi-angle light scattering (MALS). This high-throughput SEC-SAXS-MALS capability was important for validating various complex assemblies prior to cryo-EM studies.

The work reveals new targets for the development of drugs that fight certain types of cancer, including lung, colorectal, and pancreatic.

Read the ALS Science Highlight.

Was this page useful?

Send
like not like

About Biosciences

  • Leadership
  • Area Operations Centers
  • Inclusion, Diversity, Equity, and Accountability (IDEA)
  • Contact

Divisions & User Facility

  • Biological Systems and Engineering
  • Environmental Genomics and Systems Biology
  • Molecular Biophysics and Integrated Bioimaging
  • DOE Joint Genome Institute

Resources

  • A-Z Index
  • Phonebook
  • Logos
  • Acronyms
  • Integrated Safety Management
Questions & Comments
Follow us: Mastodon LinkedIn YouTube